Literature DB >> 457872

Conditioning effects of chronic infusions of dobutamine. Comparison with exercise training.

C Liang, R R Tuttle, W B Hood, H Gavras.   

Abstract

We studied the conditioning effects of chronic infusion of dobutamine and exercise training in three groups of chronically instrumented dogs. One group was infused with normal saline, a second group was infused with dobutamine (40 mug/kg per min), and the third group was exercised on a treadmill at 4 mph, up a 10 degrees incline. Each group was either infused or exercised for 2 h a day, 5 d a week for 5 consecutive wk. Resting heart rate and arterial blood lactate concentration, measured at weekly intervals, decreased progressively in the dobutamine and exercise groups, but not in the group that received normal saline infusion. Cardiovascular responses to submaximal treadmill exercise were not changed by 5 wk of normal saline infusion. However, the increases in heart rate, cardiac output, mean aortic blood pressure, arterial blood lactate, plasma renin activity, and norepinephrine concentration during exercise were significantly smaller after 5 wk of conditioning with either dobutamine or exercise training. After conditioning, the increases in arteriovenous oxygen difference during exercise were larger in the latter two groups, but the increases in total body oxygen consumption did not differ before and after conditioning. To assess ventricular function, we intravenously infused methoxamine both before and after conditioning. The slope of the line that related systolic aortic blood pressure and mean left atrial pressure increased in the animals conditioned with either dobutamine or exercise, indicating enhanced myocardial contractility. Left ventricular blood flow was lower in these two groups of animals than it was in the normal saline group. Left ventricular weight did not differ among the three groups. Our results show that chronic infusion of dobutamine produced cardiovascular and metabolic conditioning effects like those produced by exercise training, and further suggest that sympathetic stimulation during exercise plays a role in physical conditioning.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 457872      PMCID: PMC372158          DOI: 10.1172/JCI109501

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Ventricular response to a pressure load. Left ventricular function curves in intact animal.

Authors:  A V GOODYER; M J GOODKIND; A B LANDRY
Journal:  Circ Res       Date:  1962-06       Impact factor: 17.367

2.  Influence of muscular training and of catecholamines on cardiac acetylcholine and cholinesterase.

Authors:  H C HERRLICH; W RAAB; W GIGEE
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-12-01

3.  A rapid enzymic determination of L-lactic acid.

Authors:  I M FRIEDLAND; L S DIETRICH
Journal:  Anal Biochem       Date:  1961-08       Impact factor: 3.365

4.  Analysis of gas in biological fluids by gas chromatography.

Authors:  L H RAMSEY
Journal:  Science       Date:  1959-04-03       Impact factor: 47.728

5.  Control of concentration gradients of pyruvate and lactate across cell membranes in blood.

Authors:  W E HUCKABEE
Journal:  J Appl Physiol       Date:  1956-09       Impact factor: 3.531

Review 6.  Cardiovascular adaptations to physical training.

Authors:  J Scheuer; C M Tipton
Journal:  Annu Rev Physiol       Date:  1977       Impact factor: 19.318

7.  Adaptation of the rat myocardium to endurance training.

Authors:  G Tibbits; B J Koziol; N K Roberts; K M Baldwin; R J Barnard
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1978-01

Review 8.  Effect of physical training on cardiovascular adjustments to exercise in man.

Authors:  J P Clausen
Journal:  Physiol Rev       Date:  1977-10       Impact factor: 37.312

9.  The circulation of the fetus in utero. Methods for studying distribution of blood flow, cardiac output and organ blood flow.

Authors:  A M Rudolph; M A Heymann
Journal:  Circ Res       Date:  1967-08       Impact factor: 17.367

10.  Metabolic and cardiovascular responses to norepinephrine in trained and nontrained human subjects.

Authors:  J LeBlanc; M Boulay; S Dulac; M Jobin; A Labrie; S Rousseau-Migneron
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02
View more
  6 in total

1.  Prevention of bedrest-induced physical deconditioning by daily dobutamine infusions. Implications for drug-induced physical conditioning.

Authors:  M J Sullivan; P F Binkley; D V Unverferth; J H Ren; H Boudoulas; T M Bashore; A J Merola; C V Leier
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

2.  Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction.

Authors:  Cinzia Perrino; Sathyamangla V Naga Prasad; Lan Mao; Takahisa Noma; Zhen Yan; Hyung-Suk Kim; Oliver Smithies; Howard A Rockman
Journal:  J Clin Invest       Date:  2006-06       Impact factor: 14.808

3.  Intermittent cardiac overload results in adaptive hypertrophy and provides protection against left ventricular acute pressure overload insult.

Authors:  Daniel Moreira-Gonçalves; Tiago Henriques-Coelho; Hélder Fonseca; Rita Ferreira; Ana Isabel Padrão; Cátia Santa; Sara Vieira; Ana Filipa Silva; Francisco Amado; Adelino Leite-Moreira; José Alberto Duarte
Journal:  J Physiol       Date:  2015-06-23       Impact factor: 5.182

4.  Plasma renin activity and plasma catecholamines in intact and splenectomized running and swimming beagle dogs.

Authors:  J A Joles; J M den Hertog; G H Huisman; W J Kraan; F W van Schaik; A C Schrikker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

5.  Current treatment of dilated cardiomyopathy.

Authors:  E K Massin
Journal:  Tex Heart Inst J       Date:  1991

6.  Enzymatic adaptation to physical training under beta-blockade in the rat. Evidence of a beta 2-adrenergic mechanism in skeletal muscle.

Authors:  L L Ji; D L Lennon; R G Kochan; F J Nagle; H A Lardy
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.